Cardio Flashcards
Acute Coronary Syndrome - Definition
A spectrum of acute myocardial ischaemia and/or infarction.
There are 3 types:
- STEMI
- NSTEMI
- Unstable Angina
Unstable Angina - Definition & Presentations
Myocardial ischaemia at rest/on minimal excursion in the absence of acute cardiomyocyte injury/necrosis.
–> Poor blood flow through coronary artery/ies
Characterised by:
- Prolonged angina at rest >20 mins
- New onset of severe Angina
- Angina that is increasing in frequency, lasting longer, or lower in threshold
- Angina that occurs after a recent episode of Myocardial Infarction
(Does not cover pregnant women)
Presentations:
- Chest pain
- Marked sweating
- Epigastric pain
- Dyspnoea (SOB)
- Syncope (fainting)
Unstable Angina - Aetiology & Risk Factors
Underlying cause in almost all patients: Coronary Artery Disease
Most common cause: Coronary artery narrowing by a thrombus that develops on a disrupted atherosclerotic plaque, it is usually non-occlusive
Risk Factors:
(risk factors for cardiovascular diseases –> Things that will cause plaque formation)
- Diabetes Mellitus
- Hyperlipidaemia
- Hypertension
- Metabolic syndrome
- Smoking
- Obesity/inactivity
- Advanced age
Unstable Angina - Epidemiology
Cardiovascular Disease (CVD) is the leading cause of deaths globally for men and women
Unstable Angina - Differentials
1) Stable angina –> Pain only occurs on exertion/emotional distress. It doesn’t worsen over time and is relieved by nitrates & rest
2) Vasospastic angina –> Usually occurs w/out provocation and resolves spontaneously or with rapid-acting nitrates. Most episodes happen in the early morning.
Calcium channel blockers supress symptoms, beta-blockers do not
3) NSTEMI –> Can be undistinguishable
4) STEMI –> Can be undistinguishable
5) CHF (Congestive Heart Failure) –> SOB, orthopnoea, tachycardia & peripheral oedema are usually predominant.
Chest pain may occur if coronary perfusion is poor
Unstable Angina - Investigations
1st line:
- ECG
- High-sensitivity troponin –> Rule out acute MI
- CXR
- FBC
–> Check for secondary causes (i.e. anaemia is common for unstable angina and associated with increased mortality)
–>Check for thrombocytopenia as treatment of unstable angina increases risk of bleeding
- Urea, electrolytes and creatinine –> measure renal function
- LFT –> check Liver in bleeding risk assessment before starting anticoagulant
- Blood glucose
- CRP –> rule other causes
Consider:
- Echocardiography
- Invasive coronary angiography
- Functional (stress) testing
- Coronary computed tomography angiography
Unstable Angina - Management
Acute - suspected/confirmed unstable angina:
1st line:
- Aspirin (unless significant bleeding risk) - Single loading dose
–> aspirin: 300 mg orally (chewed or dispersed in water) as a loading dose, followed by 75-100 mg once daily thereafter
- P2Y12 inhibitor (not recommended if invasive coronary angiography is planned w/in 24/hrs) –> prevents blood clots
–> clopidogrel: 300 mg orally as a loading dose, followed by 75 mg once daily thereafter - Manage hyperglycaemia if needed
consider:
- Glyceryl trinitrate –> glyceryl trinitrate translingual: 400-800 micrograms administered under the tongue via aerosol spray as a single dose, may repeat every 5 minutes if required, maximum 3 dose
- Morphine –> morphine sulfate: 2.5 to 10 mg intravenously initially, followed by 2.5 to 10 mg if required (at a rate of 1-2 mg/minute)
- Anti-emetic (stops vomiting & nausea) –> ondansetron: 4-8 mg intravenously as a single dose
- Referral for invasive coronary angiography
Ongoing Unstable Angina:
1st line:
- Start/increase anti-anginal medication –> Beta-blocker (bisoprolol)
- Short-acting Nitrate - Glyceryl trinitrate (glyceryl trinitrate translingual: 400-800 micrograms administered under the tongue via aerosol spray as a single dose, may repeat every 5 minutes if required, maximum 3 dose) –> immediate relief to symptoms
- Continue Aspirin indefinitely unless the patient has a sensitivity –> aspirin: 75-100 mg once daily thereafter
consider:
- ACE inhibitor/ angiotensin II receptor antagonist –> if reduced left ventricular ejection fraction/diabetes/CKD –> ramipril: 2.5 mg orally twice daily for 3 days, increase gradually according to response, maximum 10 mg/day
- Statin –> reduce cholesterol risk –> atorvastatin: 40-80 mg orally once daily
- Aldosterone antagonist –> if reduced left ventricular ejection fraction –> spironolactone: 25 mg orally once daily initially, increase gradually according to response, maximum 50 mg/day
Unstable Angina - Prognosis & Complications
A year on there is a 10% mortality rate
Adverse prognostic markers:
- Chest pain at rest
- Comorbidities
- Signs of Left ventricular failure
- ST depression
- Elderly
Complications:
- Complication of treatment - bleeding = high
–>
- Complication of treatment - thrombocytopenia = high
- Ventricular arrythmias = high
- CHF = medium
NSTEMI - Definition & Presentations
An acute ischaemic event causing myocyte necrosis, with an ECG showing no ST elevation
–> Partial/incomplete blocking of a coronary artery
Presentations:
- Chest pain
- Marked Sweating
- Cardiogenic shock
- Nausea & vomiting
- Arrhythmias
- Heart murmur
- Epigastric pain
NSTEMI - Aetiology & Risk Factors
Usually due to a transient/incomplete occlusion of a coronary artery, depriving the myocardium of Oxygen
i.e. embolism
–> severe progressive atherosclerosis
–> recreational drug use
–> arterial inflammation
Risk Factors:
- Atherosclerosis (Hx of Angina, MI, Stroke, tec…)
- Diabetes
- Smoking
- Family Hx
- Age >65
- Hypertension
- Obesity/Physical inactivity
- Cocaine use
- CKD
- Sleep Apnoea –> Sever/untreated obstructive sleep apnoea associated with 17% increased cardiovascular risk
NSTEMI - Epidemiology
NSTEMI occurs more frequently than STEMI
Cardiovascular Disease (CVD) is the leading cause of deaths globally for men and women
NSTEMI - Differentials
1) STEMI –> Clinical presentation may not differentiate
2) Unstable Angina –> Clinical presentation may not differentiate
3) Aortic dissection
–> Pain described as ‘tearing back pain’
–> Often occurs in patients w/ collagen vascular disease (i.e. Marfan syndrome)
4) Pulmonary Embolism
–> Often present w/ dyspnoea, pleuritic chest pain, cough or haemoptysis
–> Hypoxia may be present
–> Lower limbs should be examined for DVT
5) Peptic Ulcer
–> Pain is often described as burning epigastric pain that occurs hrs after meals or with hunger
–> Often wakes the patient up at night
–> Is relieved w/ food and antacids
–> May be a previous Hx of Reflux or medicines that can cause Peptic Ulcers
6) Acute Pericarditis
–> Pain is relieved by sitting forwards
–> Friction rub or distant heart sounds may be heard on auscultation
–> Look for Hx of recent cardiac procedure, Renal failure or a preceding illness
NSTEMI - Investigations
1st line:
-ECG
- High-sensitivity Troponin –> would be elevated
- CXR
- FBC
- Urea, electrolytes and creatinine
- LFTs
- Blood glucose
- CRP
consider:
- Echocardiography
- Invasive coronary angiography
NSTEMI - Management
Acute first line:
- Refer for immediate invasive coronary angiography and/or revascularisation
- Aspirin, single loading dose (unless high bleeding risk or hypersensitivity) –> aspirin: 300 mg orally (chewed or dispersed in water) as a loading dose, followed by 75-100 mg once daily thereafter
–> consider P2Y12 inhibitor,, usually used however the use of this must be balanced between the risk of bleeding and the risk of clots.
(Aspirin and P2Y12 inhibitors together = dual antiplatelet therapy)
–> clopidogrel: 300 mg orally as a loading dose, followed by 75 mg once daily thereafter
consider:
-Oxygen -> only if sats <90%
- Glyceryl trinitrate -> pain relief –> glyceryl trinitrate translingual: 400-800 micrograms administered under the tongue via aerosol spray as a single dose, may repeat every 5 minutes if required, maximum 3 dose
- Morphine -> pain relief –> morphine sulfate: 2.5 to 10 mg intravenously initially, followed by 2.5 to 10 mg if required (at a rate of 1-2 mg/minute)
- Anti-emetic -> When giving morphine –> ondansetron: 4-8 mg intravenously as a single dose
Post-stabilisation first line:
- Continue dual antiplatelet therapy
+ Start/continue beta blocker –> bisoprolol: 1.25 mg orally once daily initially for 1 week, increase gradually according to response, maximum 10 mg/day
+ Start/continue ACE inhibitor –> ramipril: 2.5 mg orally twice daily for 3 days, increase gradually according to response, maximum 10 mg/day
+ Statin –> atorvastatin: 40-80 mg orally once daily
+ Possible cardiac rehabilitation
consider:
- Aldosterone antagonist -> if reduced LVEF –> spironolactone: 25 mg orally once daily initially, increase gradually according to response, maximum 50 mg/day
NSTEMI - Prognosis & Complications
High risk of morbidity and death in the future
predictors of poor prognosis:
-Ventricular arrythmias
- LV dysfunction
Complications (many due to LV failure/fibrillation/arrythmias):
- Cardiac arrythmias = medium chance
- Acute heart failure = low chance
- Cardiogenic shock = low chance
- Venous thromboembolism = low chance
- Ventricular rupture/aneurysm = low chance
STEMI - Definition & Presentations
Myocardial cell death that occurs due to a prolonged mismatch between perfusion and demand, usually caused by a complete occlusion of a coronary artery
Marked ST elevation on ECG that is persistent and new/increased
Presentations:
- Severe chest pain
- Dyspnoea
- Pallor
- Diaphoresis (sweating)
- Nausea/vomiting
- Dizziness
- Anxiety/distress
- Palpitations
STEMI - Aetiology & Risk Factors
Typically a thrombosis/embolism leading to complete occlusion of a coronary artery –> Resulting from Atherosclerosis
Usually a consequence of coronary artery disease
Can be due to coronary spasm or spontaneous coronary/aortic dissection
Risk Factors:
- Smoking
- Hypertension
- Diabetes
- Obesity/Inactivity
- Metabolic Syndrome
- Renal insufficiency
- Family Hx
- Male sex
- Age >50
- Cocaine use
STEMI - Epidemiology
Ischaemic Heart Death = most common cause of death globally
STEMI incidence has been decreasing
STEMI patients often younger than NSTEMI patients
STEMIs more common in men
STEMI - Differentials
1) Unstable angina –> Clinical presentation may not differentiate
2) NSTEMI –> Clinical presentation may not differentiate
3) Aortic dissection –> ‘Tearing’ chest pain between shoulder blades. Peripheral pulses may be unequal or absent distally
4) Pulmonary Embolism –> acute stabbing sharp pleuritic pain (pain on breathing), SOB, Hx of clotting disorders or long period of immobilisation
5)Pneumothorax
–> Sudden onset pleuritic chest pain and SOB
–> Tachycardia, hypotension and cyanosis
–> Hx of COPD or recent chest trauma would support this
STEMI - Investingations
1st line:
- ECG
- Coronary angiography
- Urea, electrolytes & creatinine
- Cardiac Troponin
- FBC –> check for anaemia, will influence dual anti-platelet therapies given
- Glucose –> hyperglycaemia is common
- CRP
- Serum lipids –> not useful for the acute attack but helps inform patient’s risk factor for future Cardiac events
Consider:
- ABG
- CXR
- point-of-care transthoracic echocardiogram
STEMI - Management
1st line for Acute STEMI:
- Aspirin –> aspirin: 300 mg orally (chewed or dispersed in water) as a loading dose, followed by 75-100 mg once daily thereafter
- Assess eligibility for Coronary reperfusion therapy ASAP
- Analgesia –> morphine sulfate: 2.5 to 10 mg intravenously initially, followed by 2.5 to 10 mg if required (at a rate of 1-2 mg/minute)
- Anti-emetic –> ondansetron: 4-8 mg intravenously as a single dose
consider:
- Oxygen if sats <90%
- Intravenous nitrate –> Sublingual Glyceryl trinitrate can sometimes cause spontaneous relief from a STEMI, suggesting coronary spasm w/ or w/out associated MI
–> Consider only if there is persistent chest pain after sublingual chest pain or sustained hypertension
Ongoing STEMI:
- Continue dual antiplatelet therapy
–> aspirin: 75-100 mg once daily thereafter & clopidogrel: 75 mg orally once daily
-Start/continue beta-blocker –> bisoprolol: 1.25 mg orally once daily initially for 1 week, increase gradually according to response, maximum 10 mg/day
-Start/continue ACE inhibitor –> ramipril: 2.5 mg orally twice daily for 3 days, increase gradually according to response, maximum 10 mg/day
- Statin –> atorvastatin: 40-80 mg orally once daily
Consider:
-Aldosterone antagonist –> spironolactone: 25 mg orally once daily initially, increase gradually according to response, maximum 50 mg/day
- Cardiac rehabilitation –>
Changes to diet
Reduction of alcohol consumption
Smoking cessation
Weight management
Physical exercise.
STEMI - Prognosis & Complications
Faster a STEMI is treated from onset of symptoms the better the diagnosis
Prognosis is improved by early reperfusion
Predictors for worse prognosis:
- High Troponin levels
- Major bleeding
Complications:
- CHF = high chance (decreased LV function)
- Ventricular Arrythmias = high chance
- Recurrent Ischaemia & Infarction = high chance (further plaque rupture from Atherosclerosis)
- Depression = high chance
- Recurrent chest pain = medium chance
- Sinus bradycardia, first-degree heart block & type 1 second degree heart block = medium chance
- Complete heart block w/ anterior MI = medium chance
Anaemia - Definition & Presentations
Anaemia is a haemoglobin (Hb) level two standard deviations below the mean for the age and sex of the patient
Hb <11 g/dL in children under 5 years and in pregnant women
Hb <11.5 g/dL in children aged 5 to 11 years
Hb <12 g/dL in children aged 12 to 14 years and in women (aged over 15 years)
Hb <13 g/dL in men (aged over 15 years)
General Presentations:
- Fatigue/Weakness
- Pale skin
- SOB
- Dizziness/Light-headedness
- Headaches
- Cold peripherals
- Brittle nails & Pale nail beds
- Arrhythmia/palpitations
- Sometimes craving for unusual things (i.e. clay or starch) if due to iron deficiency
- Restless Legs Syndrome
- Jaundice if haemolytic
Presentations can vary depending on the cause
Many anaemic patients with no acute or active bleeding are asymptomatic
Anaemia - Aetiology & Types + Risk Factors
Risk Factors:
- Extremes of age
- Female sex
- Lactation
- Pregnancy
Types:
- Nutrient deficiency (vit. B12/Folate/General malnutrition)
- Bone marrow disease
- Blood loss
- Anaemia of chronic disease
- Toxin exposure
- Haemolytic anaemia (Autoimmune/Infections/Uraemic syndrome)
- Genetic Disorders (Thalassaemias/Sickle cell anaemia/Hereditary spherocytosis/Glucose-6-phosphate dehydrogenase (G6PD) deficiency)
- Macrovascular disease
- Pregnancy
- Thermal burns
- Cardiovascular problems are the biggest cause of individuals being intolerant to anaemia and showing symptoms